Graphic of a human heart
heart disease icon

Heart Disease Research at MMRI

Since 1958, MMRI has been at the forefront of cutting-edge heart research. We have focused on understanding both the genetic and environmental causes to cardiovascular disease, in the hopes that we can find ways to better treat, and hopefully cure, these diseases.

Play Video

According to the American Heart Association, someone in the United States dies of cardiovascular disease every 34 seconds. This means that 2,552 people die of cardiovascular-related illness each day. At MMRI, we are working hard to change these statistics. Since 1958, we have been making significant strides in understanding the causes of heart disease and working towards finding more effective therapeutic strategies. Our cardiac research is focused on delineating the molecular and genetic effects leading to the development and onset of congenital heart diseases, heart failure, cardiometabolic diseases, inflammation, cardiomyopathies, atherosclerosis, thrombosis and arrhythmias.

Heart failure also known as congestive heart failure, is a serious condition that occurs when the heart no longer can pump enough blood to meet the body's needs. This can occur if the heart is too weak or stiff to pump properly, or when it can't fill up with enough blood to eject properly to the rest of the body. Symptoms, including shortness of breath, fatigue, and/or excessive coughing, can range from mild to severe. Heart failure can develop over time, due to chronic conditions, or can occur suddenly, due to a sudden cardiac event or injury. Conditions that can cause heart failure include arrhythmia, cardiomyopathy, coronary artery disease, heart attack and high blood pressure.

Research Labs Working on
Heart Disease

Kessinger Lab

Uses molecular imaging techniques and novel therapeutic agents to address key biological mechanisms involved in cardiovascular diseases, focusing on conditions like venous thromboembolism, fibrosis and atherosclerosis.

Kontaridis Lab

Explores the underlying causes of cardiovascular diseases in both children and adults, including congenital heart diseases, cardiomyopathies, heart failure, fibrosis, cardiac inflammation, arrhythmias, and cardiometabolic disorders, with the goal of developing innovative, life-saving treatments for these ailments.

Lin Lab

Investigates the roles of COVID-19, inflammation, and heart repair using advanced gene therapy techniques and genetic remodeling, seeking breakthroughs in understanding and treating these conditions.

McCarthy Lab

Specializes in targeted drug delivery methods to improve treatment outcomes for heart attack patients, aiming to enhance the precision and effectiveness of therapies.

Nystoriak Lab

Studies the regulation of myocardial perfusion by examining how blood flow through the heart muscle affects its overall function and pumping efficiency, aiming to improve heart health and performance.

Wu Lab

Focuses on finding preventive treatments for congenital heart diseases by researching left ventricular noncompaction (LVNC) and dilated cardiomyopathy (DCM) during embryonic development, with the aim of mitigating these conditions before birth.

News About Our
Heart Disease Research

MMRI Scientist Publishes Breakthrough Study Detailing How Ketones Improves Blood Flow to the Heart

UTICA, N.Y. – Matthew Nystoriak, Ph.D., associate professor of biomedical research and translational medicine at Masonic Medical Research Institute (MMRI),…

Read More

NIH Awards $3.7 Million Grant to MMRI Researcher Investigating Pulmonary Embolism

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) recently awarded a $3.7 million…

Read More

Maria I. Kontaridis, Ph.D., to Head National Council for the American Heart Association

On Monday, July 1, 2024, Maria Kontaridis, Ph.D., became the chair of the American Heart Association’s Basic Cardiovascular Sciences (BCVS)…

Read More

Thank You

Hope For Curing The World's Most Prominent Disease

Your generous donation to our cardiovascular research program helps us fund lifesaving research - making a significant difference in the lives of others.